Concepedia

Katrijn Bogman

KB

Statistics

Publications

14

Citations

921

H-Index

11

Active since

2001

Affiliations

Roche (Switzerland)(Current)

Reckitt Benckiser (United States)

Roche (United Kingdom)

Roche (United States)

Doctors Company (United States)

Katrijn Bogman is an author at Roche (Switzerland) specializing in pharmacology, pharmacokinetics, and medicine.

ORCID

Publications per year

2001–2024

14

Publications

14

HMG‐CoA reductase inhibitors and P‐glycoprotein modulation

Katrijn Bogman, Anne‐Kathrin Peyer, Michael Török et al. · British Journal of Pharmacology · 2001 · 193 citations · Full text

, , +13

The Role of Surfactants in the Reversal of Active Transport Mediated by Multidrug Resistance Proteins

Katrijn Bogman, Françoise Erne-Brand, Jochem Alsenz et al. · Journal of Pharmaceutical Sciences · 2003 · 183 citations

, , +14

P-glycoprotein and surfactants: Effect on intestinal talinolol absorption

Katrijn Bogman, Y ZYSSET, Lukas Degen et al. · Clinical Pharmacology & Therapeutics · 2005 · 128 citations

, , +16

Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)

Katrijn Bogman, Dietmar Schwab, Marie‐Laure Delporte et al. · Hypertension · 2016 · 107 citations · Full text

, , +17

Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects

Peter N. Morcos, Li Yu, Katrijn Bogman et al. · Xenobiotica · 2016 · 66 citations

, , +14

1–5 of 14